IMV - multiple clinical-stage candidates in immuno-oncology and infectious disease, with a focus on combination therapies.

Biotechnology

Marianne Stanford

Joanne Schindler

Marie-Eve Charrois

Joseph Sullivan

Saman Maleki

Kunle Odunsi

Kyle Kuvalanka

Michael Morse

Grant McFadden

Stanley Frankel

Jose Iglesias

Michael Kalos

The Business Development team at IMV is responsible for identifying and pursuing strategic partnerships, licensing opportunities, and collaborations that enhance the company's portfolio in immuno-oncology and infectious diseases. This team plays a crucial role in assessing market trends, negotiating deals, and fostering relationships with key stakeholders to drive the company's growth and advance its innovative combination therapies.

Business Development

The Leadership Team at IMV is responsible for strategic decision-making and guiding the overall direction of the company. This includes overseeing clinical development, financial management, regulatory compliance, and business development initiatives to advance innovative immuno-oncology and infectious disease therapies. By leveraging diverse expertise, the team aims to drive successful combination therapy programs and bring transformative treatments to market.

Leadership Team

IMV

Org chart

Board & advisors

Teams

Business Development

Leadership Team

Offices

IMV

Org chart

Board & advisors

Teams

Business Development

Leadership Team

Offices

Related companies